1 Imatinib Drug Market Overview 1.1 Product Overview and Scope of Imatinib Drug 1.2 Imatinib Drug Segment by Type 1.2.1 Global Imatinib Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Tablets 1.2.3 Capsules 1.3 Imatinib Drug Segment by Application 1.3.1 Global Imatinib Drug Sales Comparison by Application: (2021-2027) 1.3.2 Chronic Myelogenous Leukemia 1.3.3 Gastrointestinal Stromal Tumors 1.3.4 Others 1.4 Global Imatinib Drug Market Size Estimates and Forecasts 1.4.1 Global Imatinib Drug Revenue 2016-2027 1.4.2 Global Imatinib Drug Sales 2016-2027 1.4.3 Imatinib Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Imatinib Drug Market Competition by Manufacturers 2.1 Global Imatinib Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Imatinib Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Imatinib Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Imatinib Drug Manufacturing Sites, Area Served, Product Type 2.5 Imatinib Drug Market Competitive Situation and Trends 2.5.1 Imatinib Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Imatinib Drug Players Market Share by Revenue 2.5.3 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Imatinib Drug Retrospective Market Scenario by Region 3.1 Global Imatinib Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Imatinib Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Imatinib Drug Market Facts & Figures by Country 3.3.1 North America Imatinib Drug Sales by Country 3.3.2 North America Imatinib Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Imatinib Drug Market Facts & Figures by Country 3.4.1 Europe Imatinib Drug Sales by Country 3.4.2 Europe Imatinib Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Imatinib Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Imatinib Drug Sales by Region 3.5.2 Asia Pacific Imatinib Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Imatinib Drug Market Facts & Figures by Country 3.6.1 Latin America Imatinib Drug Sales by Country 3.6.2 Latin America Imatinib Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Imatinib Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Imatinib Drug Sales by Country 3.7.2 Middle East and Africa Imatinib Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Imatinib Drug Historic Market Analysis by Type 4.1 Global Imatinib Drug Sales Market Share by Type (2016-2021) 4.2 Global Imatinib Drug Revenue Market Share by Type (2016-2021) 4.3 Global Imatinib Drug Price by Type (2016-2021) 5 Global Imatinib Drug Historic Market Analysis by Application 5.1 Global Imatinib Drug Sales Market Share by Application (2016-2021) 5.2 Global Imatinib Drug Revenue Market Share by Application (2016-2021) 5.3 Global Imatinib Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Novartis 6.1.1 Novartis Corporation Information 6.1.2 Novartis Description and Business Overview 6.1.3 Novartis Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Novartis Imatinib Drug Product Portfolio 6.1.5 Novartis Recent Developments/Updates 6.2 Glenmark Pharmaceuticals Ltd. 6.2.1 Glenmark Pharmaceuticals Ltd. Corporation Information 6.2.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview 6.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Portfolio 6.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments/Updates 6.3 Sun Pharmaceuticals 6.3.1 Sun Pharmaceuticals Corporation Information 6.3.2 Sun Pharmaceuticals Description and Business Overview 6.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Sun Pharmaceuticals Imatinib Drug Product Portfolio 6.3.5 Sun Pharmaceuticals Recent Developments/Updates 6.4 Actavis Generics 6.4.1 Actavis Generics Corporation Information 6.4.2 Actavis Generics Description and Business Overview 6.4.3 Actavis Generics Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Actavis Generics Imatinib Drug Product Portfolio 6.4.5 Actavis Generics Recent Developments/Updates 6.5 Dr. Reddy's Laboratories 6.5.1 Dr. Reddy's Laboratories Corporation Information 6.5.2 Dr. Reddy's Laboratories Description and Business Overview 6.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Dr. Reddy's Laboratories Imatinib Drug Product Portfolio 6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates 6.6 Teva Pharmaceutical Industries Ltd. 6.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information 6.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview 6.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Portfolio 6.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates 6.7 Sanofi S.A. 6.6.1 Sanofi S.A. Corporation Information 6.6.2 Sanofi S.A. Description and Business Overview 6.6.3 Sanofi S.A. Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi S.A. Imatinib Drug Product Portfolio 6.7.5 Sanofi S.A. Recent Developments/Updates 6.8 Cipla Inc. 6.8.1 Cipla Inc. Corporation Information 6.8.2 Cipla Inc. Description and Business Overview 6.8.3 Cipla Inc. Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Cipla Inc. Imatinib Drug Product Portfolio 6.8.5 Cipla Inc. Recent Developments/Updates 6.9 Apotex Inc. 6.9.1 Apotex Inc. Corporation Information 6.9.2 Apotex Inc. Description and Business Overview 6.9.3 Apotex Inc. Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Apotex Inc. Imatinib Drug Product Portfolio 6.9.5 Apotex Inc. Recent Developments/Updates 6.10 Mylan Pharms Inc. 6.10.1 Mylan Pharms Inc. Corporation Information 6.10.2 Mylan Pharms Inc. Description and Business Overview 6.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Mylan Pharms Inc. Imatinib Drug Product Portfolio 6.10.5 Mylan Pharms Inc. Recent Developments/Updates 7 Imatinib Drug Manufacturing Cost Analysis 7.1 Imatinib Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Imatinib Drug 7.4 Imatinib Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Imatinib Drug Distributors List 8.3 Imatinib Drug Customers 9 Imatinib Drug Market Dynamics 9.1 Imatinib Drug Industry Trends 9.2 Imatinib Drug Growth Drivers 9.3 Imatinib Drug Market Challenges 9.4 Imatinib Drug Market Restraints 10 Global Market Forecast 10.1 Imatinib Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Imatinib Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Imatinib Drug by Type (2022-2027) 10.2 Imatinib Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Imatinib Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Imatinib Drug by Application (2022-2027) 10.3 Imatinib Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Imatinib Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Imatinib Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Imatinib Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Imatinib Drug Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Imatinib Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Imatinib Drug Covered in This Study Table 5. Global Imatinib Drug Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Imatinib Drug Sales Market Share by Manufacturers (2016-2021) Table 7. Global Imatinib Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Imatinib Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Imatinib Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Imatinib Drug Manufacturing Sites and Area Served Table 11. Manufacturers Imatinib Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Imatinib Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imatinib Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Imatinib Drug Sales by Region (2016-2021) & (K Units) Table 16. Global Imatinib Drug Sales Market Share by Region (2016-2021) Table 17. Global Imatinib Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Imatinib Drug Sales by Country (2016-2021) & (K Units) Table 19. North America Imatinib Drug Sales Market Share by Country (2016-2021) Table 20. North America Imatinib Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Imatinib Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Imatinib Drug Sales by Country (2016-2021) & (K Units) Table 23. Europe Imatinib Drug Sales Market Share by Country (2016-2021) Table 24. Europe Imatinib Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Imatinib Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Imatinib Drug Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Imatinib Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Imatinib Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Imatinib Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Imatinib Drug Sales by Country (2016-2021) & (K Units) Table 31. Latin America Imatinib Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Imatinib Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Imatinib Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Imatinib Drug Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Imatinib Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Imatinib Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Imatinib Drug Revenue Market Share by Country (2016-2021) Table 38. Global Imatinib Drug Sales (K Units) by Type (2016-2021) Table 39. Global Imatinib Drug Sales Market Share by Type (2016-2021) Table 40. Global Imatinib Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Imatinib Drug Revenue Share by Type (2016-2021) Table 42. Global Imatinib Drug Price (USD/Unit) by Type (2016-2021) Table 43. Global Imatinib Drug Sales (K Units) by Application (2016-2021) Table 44. Global Imatinib Drug Sales Market Share by Application (2016-2021) Table 45. Global Imatinib Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Imatinib Drug Revenue Share by Application (2016-2021) Table 47. Global Imatinib Drug Price (USD/Unit) by Application (2016-2021) Table 48. Novartis Corporation Information Table 49. Novartis Description and Business Overview Table 50. Novartis Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Novartis Imatinib Drug Product Table 52. Novartis Recent Developments/Updates Table 53. Glenmark Pharmaceuticals Ltd. Corporation Information Table 54. Glenmark Pharmaceuticals Ltd. Description and Business Overview Table 55. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Table 57. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates Table 58. Sun Pharmaceuticals Corporation Information Table 59. Sun Pharmaceuticals Description and Business Overview Table 60. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Sun Pharmaceuticals Imatinib Drug Product Table 62. Sun Pharmaceuticals Recent Developments/Updates Table 63. Actavis Generics Corporation Information Table 64. Actavis Generics Description and Business Overview Table 65. Actavis Generics Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Actavis Generics Imatinib Drug Product Table 67. Actavis Generics Recent Developments/Updates Table 68. Dr. Reddy's Laboratories Corporation Information Table 69. Dr. Reddy's Laboratories Description and Business Overview Table 70. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Dr. Reddy's Laboratories Imatinib Drug Product Table 72. Dr. Reddy's Laboratories Recent Developments/Updates Table 73. Teva Pharmaceutical Industries Ltd. Corporation Information Table 74. Teva Pharmaceutical Industries Ltd. Description and Business Overview Table 75. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Table 77. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates Table 78. Sanofi S.A. Corporation Information Table 79. Sanofi S.A. Description and Business Overview Table 80. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Sanofi S.A. Imatinib Drug Product Table 82. Sanofi S.A. Recent Developments/Updates Table 83. Cipla Inc. Corporation Information Table 84. Cipla Inc. Description and Business Overview Table 85. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Cipla Inc. Imatinib Drug Product Table 87. Cipla Inc. Recent Developments/Updates Table 88. Apotex Inc. Corporation Information Table 89. Apotex Inc. Description and Business Overview Table 90. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Apotex Inc. Imatinib Drug Product Table 92. Apotex Inc. Recent Developments/Updates Table 93. Mylan Pharms Inc. Corporation Information Table 94. Mylan Pharms Inc. Description and Business Overview Table 95. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Mylan Pharms Inc. Imatinib Drug Product Table 97. Mylan Pharms Inc. Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Imatinib Drug Distributors List Table 101. Imatinib Drug Customers List Table 102. Imatinib Drug Market Trends Table 103. Imatinib Drug Growth Drivers Table 104. Imatinib Drug Market Challenges Table 105. Imatinib Drug Market Restraints Table 106. Global Imatinib Drug Sales Forecast by Type (2022-2027) & (K Units) Table 107. Global Imatinib Drug Sales Market Share Forecast by Type (2022-2027) Table 108. Global Imatinib Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 109. Global Imatinib Drug Revenue Market Share Forecast by Type (2022-2027) Table 110. Global Imatinib Drug Sales Forecast by Application (2022-2027) & (K Units) Table 111. Global Imatinib Drug Sales Market Share Forecast by Application (2022-2027) Table 112. Global Imatinib Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 113. Global Imatinib Drug Revenue Market Share Forecast by Application (2022-2027) Table 114. Global Imatinib Drug Sales Forecast by Region (2022-2027) & (K Units) Table 115. Global Imatinib Drug Sales Market Share Forecast by Region (2022-2027) Table 116. Global Imatinib Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 117. Global Imatinib Drug Revenue Market Share Forecast by Region (2022-2027) Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Imatinib Drug Figure 2. Global Imatinib Drug Market Share by Type in 2020 & 2027 Figure 3. Tablets Product Picture Figure 4. Capsules Product Picture Figure 5. Global Imatinib Drug Market Share by Application in 2020 & 2027 Figure 6. Chronic Myelogenous Leukemia Figure 7. Gastrointestinal Stromal Tumors Figure 8. Others Figure 9. Global Imatinib Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Imatinib Drug Market Size 2016-2027 (US$ Million) Figure 11. Global Imatinib Drug Sales 2016-2027 (K Units) Figure 12. Global Imatinib Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Imatinib Drug Sales Share by Manufacturers in 2020 Figure 14. Global Imatinib Drug Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Imatinib Drug Players: Market Share by Revenue in 2020 Figure 16. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Imatinib Drug Sales Market Share by Region (2016-2021) Figure 18. Global Imatinib Drug Sales Market Share by Region in 2020 Figure 19. Global Imatinib Drug Revenue Market Share by Region (2016-2021) Figure 20. Global Imatinib Drug Revenue Market Share by Region in 2020 Figure 21. U.S. Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Imatinib Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Imatinib Drug by Type (2016-2021) Figure 46. Sales Market Share of Imatinib Drug by Application (2016-2021) Figure 47. Sales Market Share of Imatinib Drug by Application in 2020 Figure 48. Revenue Share of Imatinib Drug by Application (2016-2021) Figure 49. Revenue Share of Imatinib Drug by Application in 2020 Figure 50. Manufacturing Cost Structure of Imatinib Drug Figure 51. Manufacturing Process Analysis of Imatinib Drug Figure 52. Imatinib Drug Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Novartis Glenmark Pharmaceuticals Ltd. Sun Pharmaceuticals Actavis Generics Dr. Reddy's Laboratories Teva Pharmaceutical Industries Ltd. Sanofi S.A. Cipla Inc. Apotex Inc. Mylan Pharms Inc.